Drug & supplement interaction

Indole-3-carbinol + Asciminib

Asciminib brand name: Scemblix.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Indole-3-carbinol and Asciminib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the label for Asciminib states a food rule worth keeping to, and the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Interaction report

Indole-3-carbinol and Asciminib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Asciminib and Indole-3-carbinol in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Indole-3-carbinol safety at a glance

Indole-3-carbinol overall Use caution Likely fine in food amounts, but supplement doses are less studied and should be used cautiously.
Pregnancy Avoid Not enough safety data and possible hormone effects, so concentrated supplements should be avoided.
Breastfeeding Avoid Safety has not been established, so supplement use is not recommended while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Asciminib and Indole-3-carbinol? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Asciminib

Interactions in our licensed database are recorded against drug classes, not just single drug names. Asciminib is filed under 3 classifications — cytochrome p450 2c9 (cyp2c9) inhibitors, cytochrome p450 3a4 (cyp3a4) inhibitors, oral drugs. Indole-3-carbinol has documented interactions with 3 drug classes — the most serious being anticoagulant/antiplatelet drugs (moderate), cytochrome p450 1a2 (cyp1a2) substrates (moderate) and estrogens (moderate) — and none of Asciminib’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Indole-3-carbinol Does Interact With Other Medications

Indole-3-carbinol has 294 moderate known drug interactions in our database — Asciminib isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Indole-3-carbinol

Covers the 2,830 medications we’ve checked against Indole-3-carbinol. Pick one to open its full report.

What to actually watch for

No Interaction Found — But Data Suggests Indole-3-carbinol and Asciminib May Share Several of the Same Side Effects

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do.

  • Diarrhea reported in 4.1% of FDA reports for Asciminib Additional detail

    Indole-3-carbinol

    “Orally, indole-3-carbinol increases gastrointestinal motility and has been associated with diarrhea.”

    Indole-3-carbinol · Natural Medicines adverse-effect record, reported in diarrhea.

    2 sources cited
    1. 93242. Reed GA, Peterson KS, Smith HJ, et al. A phase I study of indole-3-carbinol in women: tolerability and effects. Cancer Epidemiol Biomarkers Prev 2005;14:1953-60. PubMed
    2. 93243. Bradlow HL, Michnovicz JJ, Halper M, et al. Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiol Biomarkers Prev 1994;3:591-5.

    Asciminib

    Listed in the ADVERSE REACTIONS section of the FDA label for Asciminib, and in voluntary FDA adverse-event reports. Read the label on DailyMed ›

  • Nausea reported in 5.5% of FDA reports for Asciminib Additional detail

    Indole-3-carbinol

    “Indole-3-carbinol has been associated with reports of unsteadiness and imbalance, especially at higher doses. An adult male taking 400 mg twice daily for treatment of recurrent respiratory papillomatosis developed imbalance and tremor after 10 days of treatment. This resolved when the dose was halved.”

    Indole-3-carbinol · Natural Medicines adverse-effect record, reported in myasthenia gravis.

    2 sources cited
    1. 7172. Rosen CA, Woodson GE, Thompson JW, et al. Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 1998;118:810-5. PubMed
    2. 93238. Anon. Indole-3-carbinol. Monograph. Alternative Medicine Review 2005;10(4):337-42.

    Asciminib

    Listed in the ADVERSE REACTIONS section of the FDA label for Asciminib, and in voluntary FDA adverse-event reports. Read the label on DailyMed ›

  • A skin rash Additional detail

    Indole-3-carbinol

    “Orally, indole-3-carbinol has been associated with reports of rash. A woman taking indole-3-carbinol 375 mg daily for treatment of systemic lupus erythematosus (SLE) developed a generalized maculopapular rash which resolved when indole-3-carbinol was discontinued and recurred when it was restarted.”

    Indole-3-carbinol · Natural Medicines adverse-effect record, reported in myasthenia gravis.

    2 sources cited
    1. 93242. Reed GA, Peterson KS, Smith HJ, et al. A phase I study of indole-3-carbinol in women: tolerability and effects. Cancer Epidemiol Biomarkers Prev 2005;14:1953-60. PubMed
    2. 93240. McAlindon TE, Gulin J, Chen T, et al. Indole-3-carbinol in women with SLE: effect on estrogen metabolism and disease activity. Lupus 2001;10:779-83. PubMed

    Asciminib

    Listed in the ADVERSE REACTIONS section of the FDA label for Asciminib. Read the label on DailyMed ›

Reported for Indole-3-carbinol but not commonly for Asciminib: unsteadiness and tremor or shakiness.

Effects for Asciminib come from the ADVERSE REACTIONS section of its FDA label; effects for Indole-3-carbinol come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 3,174 voluntary FDA FAERS reports for Asciminib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

How to take them

Some Asciminib Products Have a Food Rule — Indole-3-carbinol Should Not Break It

At least one FDA label for a product containing Asciminib says to take it on an empty stomach. Most supplements — Indole-3-carbinol included — are taken with a meal, so the easy mistake is swallowing both together at breakfast. Where that rule applies, keep Asciminib on its own and move Indole-3-carbinol to a meal later in the day.

This may not be true of your version. Food instructions belong to the product, not the ingredient: two Asciminib products can carry different directions, and extended-release forms often differ from immediate-release ones. The label we read is quoted below — check the directions on your own box or bottle, or ask your pharmacist, for how to take the exact product you were given.

The recommended dose of SCEMBLIX is taken orally without food.

From the Dosage and Administration section of the FDA label we read for Asciminib — where that label names a specific product, the instruction is that product's. Read the label on DailyMed ›

A food rule is not an interaction — it is about how much of the medicine you absorb. The directions that came with your own product, and your pharmacist, outrank anything on this page.

Everything else you take

See Every Supplement That Interacts With Asciminib

This page covers Indole-3-carbinol only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Asciminib page lists 31 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Adrafinil (moderate), Cannabidiol (cbd) (moderate), Cannabinol (cbn) (moderate) and Cannabis (moderate).

By severity: 1 major · 20 moderate · 10 minor.

From our pharmacist’s overview on the Asciminib page

“Asciminib (Scemblix) treats chronic myeloid leukemia, and a steady blood level is what keeps the cancer suppressed, so this list deserves real care rather than a quick skim. Seventeen of the 31 supplements on file are fibers, gums, and charcoals that can block or slow how much of each pill your gut actually absorbs.”

Reviewed by 2 · Jul 18, 2026

Open the Asciminib interaction page

One more smart check

Taking Indole-3-carbinol as Part of a Dietary Supplement Product? Check It for Interactions

We hold 287 real supplement products containing Indole-3-carbinol, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Indole-3-carbinol. Even though Indole-3-carbinol itself has no known interaction with Asciminib, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Indole-3-carbinol and Asciminib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Indole-3-carbinol
Top half

#397 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Asciminib
Top half

#1,253 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Indole-3-carbinol reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Indole-3-carbinol and Asciminib records this page draws on were last updated July 10, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Indole-3-carbinol

What is Indole-3-carbinol?

  • Estrogen and hormone balance support
  • Breast and cervical health
  • Prostate health
  • Antioxidant and 'detox' support
  • General cancer-prevention interest

Indole-3-carbinol (I3C) is a compound formed when you eat cruciferous vegetables like broccoli and cabbage, and it is sold as a supplement mainly for hormone-related and cell-protective effects. Most human evidence is preliminary or comes from lab and animal studies, so it should not be relied on to prevent or treat any disease. Talk to your pharmacist or doctor before using it, and avoid it in pregnancy and breastfeeding.

Brassicaceae · Derived from glucosinolates found in cruciferous vegetables (broccoli, cabbage, Brussels sprouts, cauliflower) · Capsules, tablets, softgels; sometimes combined with or compared to diindolylmethane (DIM)

An interaction check asks whether these two react with each other — it does not ask whether Indole-3-carbinol is a good idea for someone in your situation. Here is what our Indole-3-carbinol record says about it on its own.

Indole-3-carbinol: dosing

There is no officially established or standardized dose for I3C. Different products and studies have used different amounts, and there is no agreed-upon 'best' dose.The safest approach is to follow the directions on the product label and not exceed them. They can help you decide whether I3C is appropriate for you.

From our Indole-3-carbinol monograph — the full record covers uses, side effects and every documented interaction.

Read the full Indole-3-carbinol monograph & all interactions
Medication

About Asciminib

What Is Asciminib Used For?

Brand name: Scemblix

Scemblix (asciminib) is used to treat adult patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP) — a type of blood cancer driven by an abnormal protein called BCR-ABL1. It covers three groups: people newly diagnosed with Ph+ CML-CP, people who have already been treated for Ph+ CML-CP, and people whose cancer carries a specific mutation called T315I that makes it harder to treat.

The use in newly diagnosed Ph+ CML-CP was approved under accelerated approval based on early response data. Continued approval for that specific use may depend on results from confirmatory trials confirming long-term clinical benefit.

Most-Reported Side Effects for Asciminib

From FAERS, the FDA’s public side-effect reporting system (3,174 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Fatigue 252 reports
Nausea 175 reports
Thrombocytopenia 158 reports
Headache 134 reports
Diarrhea 130 reports
See full Asciminib drug information
Keep checking

Other Drugs & Indole-3-carbinol

Browse every other medication we’ve checked against Indole-3-carbinol — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
294Moderate
0Minor
2,535No known interaction
Moderate

294 interactions

Showing 60 of 294 moderate interactions — see all 294 on the Indole-3-carbinol page.

No interaction 2,535 drugs checked — show the list
Evidence & sources

Indole-3-carbinol References

The 9 references that drive our Indole-3-carbinol monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Rosen CA, Woodson GE, Thompson JW, et al. Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 1998;118:810-5. PubMed
  2. Bell MC, Crowley-Nowick P, Bradlow HL, et al. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 2000;78:123-9. PubMed
  3. He YH, Friesen MD, Ruch RJ, Schut HA. Indole-3-carbinol as a chemopreventive agent in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) carcinogenesis: inhibition of PhIP-DNA adduct formation, acceleration of PhIP metabolism, and induction of cytoch
  4. Kim, Y. S. and Milner, J. A. Targets for indole-3-carbinol in cancer prevention. J.Nutr.Biochem. 2005;16(2):65-73. PubMed
  5. Anon. Indole-3-carbinol. Monograph. Alternative Medicine Review 2005;10(4):337-42.
  6. McAlindon TE, Gulin J, Chen T, et al. Indole-3-carbinol in women with SLE: effect on estrogen metabolism and disease activity. Lupus 2001;10:779-83. PubMed
  7. Reed GA, Peterson KS, Smith HJ, et al. A phase I study of indole-3-carbinol in women: tolerability and effects. Cancer Epidemiol Biomarkers Prev 2005;14:1953-60. PubMed
  8. Bradlow HL, Michnovicz JJ, Halper M, et al. Long-term responses of women to indole-3-carbinol or a high fiber diet. Cancer Epidemiol Biomarkers Prev 1994;3:591-5.
  9. Paliwal P, Chauhan G, Gautam D, Dash D, Patne SCU, Krishnamurthy S. Indole-3-carbinol improves neurobehavioral symptoms in a cerebral ischemic stroke model. Naunyn Schmiedebergs Arch Pharmacol. 2018;391(6):613-625. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Indole-3-carbinol and Asciminib Together: Common Questions

Is it safe to take Indole-3-carbinol with Asciminib?
We do not list a known interaction between Indole-3-carbinol and Asciminib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Indole-3-carbinol and Asciminib have any of the same side effects?
Yes — our sources link each of them separately to 3 of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Should I take Indole-3-carbinol and Asciminib at the same time of day?
At least one FDA label for a product containing Asciminib says to take it on an empty stomach, and supplements are usually taken with a meal — so taking them together at breakfast is the easy mistake. Where that applies, keep Asciminib on its own and move Indole-3-carbinol to a meal later in the day. Food instructions belong to the product rather than the ingredient, so check the directions on your own box. This is about absorption, not an interaction.
How was the Indole-3-carbinol and Asciminib combination checked?
Interactions in our licensed database are recorded against drug classes. Asciminib is filed under 3 classifications, and Indole-3-carbinol has documented interactions with 3 drug classes — none of Asciminib's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Indole-3-carbinol interact with any other medications?
Yes. Indole-3-carbinol has 294 documented drug interactions in our database — Asciminib is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Asciminib interact with any supplements?
Yes. Asciminib has documented interactions with 31 supplements in our database — Indole-3-carbinol is not one of them. The Asciminib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Asciminib and Indole-3-carbinol?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.